Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Opus Genetics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 36 | 30 | −6 |
| Shares | 1.07M | 1.68M | +611.0K (+57.2%) |
| Value | $5.61M | $8.62M | +$3.02M (+53.8%) |
New holders (6)
Institutions that held Opus Genetics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 43,900 | $226.0K | 0.00% |
| Two Sigma Investments, LP | 36,883 | $190.0K | 0.00% |
| Millennium Management LLC | 26,427 | $136.0K | 0.00% |
| Frontier Wealth Management LLC | 25,000 | $129.0K | 0.01% |
| LPL Financial LLC | 20,024 | $103.0K | 0.00% |
| Northern Trust Corp | 12,131 | $62.0K | 0.00% |
Sold out (12)
Institutions that held Opus Genetics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Marshall Wace, LLP | 329,131 | $1.74M |
| Norris Perne & French LLP | 78,909 | $417.0K |
| Goldman Sachs Group Inc | 37,315 | $197.0K |
| Renaissance Technologies LLC | 35,529 | $188.0K |
| Jane Street Group, LLC | 24,984 | $132.0K |
| Squarepoint Ops LLC | 19,395 | $102.0K |
| Man Group plc | 14,900 | $79.0K |
| Cutler Group LP | 7,900 | $41.0K |
| Tower Research Capital LLC (TRC) | 3,312 | $17.0K |
| Deutsche Bank AG | 1,400 | $7.00K |
| Salem Investment Counselors Inc | 10 | $0 |
| Close Asset Management Ltd | 20 | $0 |